Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 11/20 | 0.39 |
| ▸ | NPY1R | P25929 | 9/20 | 0.39 |
| ▸ | NPY5R | Q15761 | 8/20 | 0.39 |
| ▸ | TERT | O14746 | 1/20 | 0.37 |
| ▸ | NOD1 | Q9Y239 | 3/20 | 0.36 |
| ▸ | NPY2R | P49146 | 5/20 | 0.36 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.34 |
| ▸ | ENPEP | Q07075 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29678580 | 0.94 | TERT (0.42) | NPY4RNPY1RNPY5RTERTNOD1 | |
| SCHEMBL31265334 | 0.90 | NPY4R (0.41) | NPY4RNPY1RNPY5RNOD1NPY2R | |
| SCHEMBL30541579 | 0.88 | NPY4R (0.41) | NPY4RNPY1RNPY5RNPY2RRXFP1 | |
| SCHEMBL27732271 | 0.88 | NPY4R (0.40) | NPY4RNPY1RNPY5RNOD1NPY2R | |
| SCHEMBL9614927 | 0.88 | NPY4R (0.40) | NPY4RNPY1RNPY5RNOD1NPY2R | |
| SCHEMBL15011349 | 0.88 | NPY4R (0.40) | NPY4RNPY1RNPY5RNOD1NPY2R | |
| SCHEMBL30988902 | 0.88 | NPY4R (0.48) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL29587324 | 0.87 | ENPEP (0.42) | NPY4RNPY1RNPY5RNOD1NPY2R | |
| SCHEMBL15268407 | 0.87 | RXFP1 (0.42) | NPY4RNPY1RNPY5RNOD1NPY2R | |
| SCHEMBL15268406 | 0.87 | RXFP1 (0.42) | NPY4RNPY1RNPY5RNOD1NPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4716851-A2 | ACTIVATION MARKERS OF T CELLS AND METHOD FOR ASSESSING T CELL ACTIVATION | Juno Therapeutics, Inc. (US) | 2026-04-01 | — | — | EP | disclosed |
| WO-2024243365-A2 | ACTIVATION MARKERS OF T CELLS AND METHOD FOR ASSESSING T CELL ACTIVATION | JUNO THERAPEUTICS, INC. (US) | 2024-11-28 | — | — | WO | disclosed |
| US-20240191188-A1 | METHODS FOR CULTURING CELLS AND KITS AND APPARATUS FOR SAME | JUNO THERAPEUTICS GMBH (DE) | 2024-06-13 | — | — | US | disclosed |